Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsJNDOF 85 EV-to-EBIT is 13.16 as of Jul. 25, 2026, which is 55% below its 10-year median of 29.16. GuruFocus rates JNDOF with a GF Score™ of 85/100 and a GF Value™ of $38.70 (Significantly Overvalued). Among 465 Medical Devices & Instruments companies, JINS Holdings ranks better than 66.67% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
JINS Holdings's Enterprise Value for the quarter that ended in Feb. 2026 was $506.4 Mil.
JINS Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $73.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JINS Holdings EV-to-EBIT Related Terms
JINS Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for JINS Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JINS Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where JINS Holdings's EV-to-EBIT falls into.
JINS Holdings's current Enterprise Value is $969.0 Mil.
JINS Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $73.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JINS Holdings (JNDOF) has a EV-to-EBIT of 13.16 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JINS Holdings and its competitors. This is 55% below median its historical median of 29.16. Over the past decade, JINS Holdings' EV-to-EBIT has ranged from 9.74 to 71.51. According to the industry distribution chart, JINS Holdings ranks #155 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 33.3%.
Is JINS Holdings' EV-to-EBIT too high?
JINS Holdings' current EV-to-EBIT of 13.16 is 55% below median its 10-year median of 29.16. Over the past 10 years, this metric has ranged from a low of 9.74 to a high of 71.51. The Medical Devices & Instruments industry median EV-to-EBIT is 18.19. JINS Holdings' value of 13.16 is 27.7% below this industry median. Based on the distribution chart, JINS Holdings ranks #155 out of 465 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JINS Holdings has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #155 out of 465 companies for EV-to-EBIT. This puts JINS Holdings in the upper half of its industry. The industry median EV-to-EBIT is 18.19. JINS Holdings' value of 13.16 is 27.7% below this benchmark. Historically, JINS Holdings' own EV-to-EBIT has ranged from 9.74 to 71.51 over the past decade. While the company's 10-year median is 29.16 vs. the industry median of 18.19, JINS Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.19, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current EV-to-EBIT of 13.16 is 27.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current EV-to-EBIT is 13.16, which is 55% below median its own 10-year median of 29.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
Based on GuruFocus' analysis, JINS Holdings (JNDOF) is currently considered Significantly Overvalued. The stock's GF Value™ is $38.70, compared to a current price of $38.43 — trading 0.7% below its estimated fair value. The current EV-to-EBIT is 13.16, which is 55% below median its 10-year median of 29.16 and 27.7% below the Medical Devices & Instruments industry median of 18.19. JINS Holdings' overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For JINS Holdings (JNDOF), the current EV-to-EBIT is 13.16 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (JNDOF) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of $38.43 is trading 0.7% below its estimated GF Value™ of $38.70.
GuruFocus considers JINS Holdings to be Significantly Overvalued.
Key valuation signals for JNDOF:
EV-to-EBIT: 13.16 (55% below median its 10-year median of 29.16)
GF Value™: $38.70 vs. price of $38.43 (0.7% below fair value)
Industry Position: 27.7% below the Medical Devices & Instruments median (#155 of 465)
No single metric tells the full story. See the JNDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
85GF Score
Get the complete analysis for JNDOF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JNDOF has been successfully added to your 
